Dalmia Bharat targets 130 mtpa capacity, open to organic growth and acquisitions Phase II expansion to further reinforce the company’s position as a pan-India pure-play cement player ...

London - 9 July 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that the U.S. Food and Drug Administration (FDA ...

The Phase I/II clinical trial is expected to initiate in Q4 2025 and will evaluate local administration of PS-002 to treat IgAN. In the Phase 1 part of the study the main read-outs will be safety ...

Phase transitions and critical phenomena articles from across Nature Portfolio Phase transitions and critical phenomena are the changes of a system from one regime or state to another exhibiting ...

With the advancements in modern imaging techniques, such as MRI, CT imaging, and nuclear medicine, powerful functional imaging modalities have emerged. The human skull, as a barrier for energy ...

BOSTON - Seaport Therapeutics has dosed the first patient in its Phase 2b BUOY-1 study testing GlyphAllo (SPT-300) in major depressive disorder (MDD), according to a Thursday statement from parent ...

LONDON, UK I July 09, 2025 I Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that the U.S. Food and Drug ...